🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Rite Aid files for bankruptcy, reaches agreement on restructuring with creditors

EditorPollock Mondal
Published 2023-10-16, 05:54 a/m
© Reuters.
US90274J5618=UBSS
-

Rite Aid Corporation (NYSE:RAD) said it has reached an agreement in principle with some senior secured noteholders on terms of a financial restructuring plan.

The company filed for Chapter 11 bankruptcy on Sunday.

Rite Aid has received a commitment for $3.45 billion in new financing to support business operations, and announced the acquisition of Rite Aid’s Elixir Solutions business by MedImpact Healthcare Systems, serving as the stalking horse bidder in a court-supervised sale process.

The deal is subject to higher and better offers, court approval, and other customary conditions. Elixir Insurance is not included in Rite Aid’s Chapter 11 process or proposed deal with MedImpact.

A new CEO and Chief Restructuring Officer has been named, replacing interim CEO Elizabeth Burr, who will continue in her role as a board director.

The pharmacy chain had a total debt of $8.60B as of June 3.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.